|
| BW body weight, naive (local parameter)
36101
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
|
|
3 |
1 |
3 |
5 |
5 |
3 |
3 |
3 |
1 |
3 |
3 |
3 |
2 |
|
|
| BW_2_ctrl body weight, t=2h (local parameter)
36102
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BW_8_ctrl body weight, t=8h (local parameter)
36103
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
1 |
|
| BW_24_ctrl body weight, t=24h (local parameter)
36104
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BW_2_tce body weight, t=2h (local parameter)
36107
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BW_8_tce body weight, t=8h (local parameter)
36108
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
| BW_24_tce body weight, t=24h (local parameter)
36109
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| ALT alanine transaminase (serum ALT), naive
36111
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
1 |
3 |
3 |
5 |
5 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
2 |
|
|
| ALT_2_ctrl alanine transaminase (serum ALT), control group
, 2h after baseline
36112
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
|
|
| ALT_8_ctrl alanine transaminase (serum ALT), control group
, 8h after baseline
36113
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
1 |
|
| ALT_24_ctrl alanine transaminase (serum ALT), control group
, 24h after baseline
36114
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
|
|
| ALT_2_tce alanine transaminase (serum ALT), treated group
, 2h after treatment
36117
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| ALT_8_tce alanine transaminase (serum ALT), treated group
, 8h after treatment
36118
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
| ALT_24_tce alanine transaminase (serum ALT), treated group
, 24h after treatment
36119
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| AST aspartate transaminase (serum AST), naive
36121
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
2 |
3 |
3 |
5 |
4 |
|
3 |
3 |
3 |
1 |
3 |
3 |
2 |
|
|
| AST_2_ctrl aspartate transaminase (serum AST), control group
, 2h after baseline
36122
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| AST_8_ctrl aspartate transaminase (serum AST), control group
, 8h after baseline
36123
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
2 |
2 |
3 |
3 |
3 |
1 |
|
| AST_24_ctrl aspartate transaminase (serum AST), control group
, 24h after baseline
36124
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
|
2 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| AST_2_tce aspartate transaminase (serum AST), treated group
, 2h after treatment
36127
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| AST_8_tce aspartate transaminase (serum AST), treated group
, 8h after treatment
36128
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
| AST_24_tce aspartate transaminase (serum AST), treated group
, 24h after treatment
36129
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BUN blood urea nitrogen (serum BUN), naive
36131
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
2 |
3 |
3 |
5 |
5 |
|
3 |
3 |
3 |
3 |
3 |
3 |
2 |
|
|
| BUN_2_ctrl blood urea nitrogen (serum BUN), control group
, 2h after baseline
36132
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BUN_8_ctrl blood urea nitrogen (serum BUN), control group
, 8h after baseline
36133
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
2 |
3 |
3 |
3 |
3 |
1 |
|
| BUN_24_ctrl blood urea nitrogen (serum BUN), control group
, 24h after baseline
36134
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BUN_2_tce blood urea nitrogen (serum BUN), treated group
, 2h after treatment
36137
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| BUN_8_tce blood urea nitrogen (serum BUN), treated group
, 8h after treatment
36138
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
| BUN_24_tce blood urea nitrogen (serum BUN), treated group
, 24h after treatment
36139
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| LW_adj liver weight as percent of body weight, naive
36141
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
|
|
3 |
1 |
3 |
5 |
5 |
3 |
3 |
3 |
1 |
3 |
3 |
3 |
2 |
|
|
| LW_adj2_ctrl liver weight as percent of body weight, t=2h (local parameter)
36142
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| LW_adj8_ctrl liver weight as percent of body weight, t=8h (local parameter)
36143
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
1 |
|
| LW_adj24_ctrl liver weight as percent of body weight, t=24h (local parameter)
36144
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| LW_adj2_tce liver weight as percent of body weight, t=2h (local parameter)
36147
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| LW_adj8_tce liver weight as percent of body weight, t=8h (local parameter)
36148
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
| LW_adj24_tce liver weight as percent of body weight, t=24h (local parameter)
36149
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| DCA_2_tce dichloroacetic acid (serum DCA x 10-3)
, 2h after treatment
36167
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
1 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
2 |
|
|
| DCA_8_tce dichloroacetic acid (serum DCA x 10-3)
, 8h after treatment
36168
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
2 |
1 |
3 |
2 |
|
|
| DCA_24_tce dichloroacetic acid (serum DCA x 10-3)
, 24h after treatment
36169
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
2 |
|
3 |
3 |
1 |
3 |
1 |
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
|
|
| TCA_2_tce trichloroacetic acid (serum TCA)
, 2h after treatment
36175
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
1 |
|
3 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
2 |
|
|
| TCA_8_tce trichloroacetic acid (serum TCA)
, 8h after treatment
36176
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
3 |
|
3 |
3 |
3 |
3 |
3 |
2 |
3 |
3 |
3 |
2 |
1 |
3 |
2 |
|
|
| TCA_24_tce trichloroacetic acid (serum TCA)
, 24h after treatment
36177
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
2 |
|
3 |
3 |
2 |
3 |
1 |
1 |
2 |
3 |
3 |
|
3 |
3 |
|
|
|
| DCV_cysteine2_tce DCV cysteine (serum DCVC x 10-3)
, 2h after treatment
36185
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
1 |
|
3 |
2 |
3 |
3 |
3 |
2 |
2 |
3 |
2 |
2 |
1 |
3 |
1 |
|
|
| DCV_cysteine8_tce DCV cysteine (serum DCVC x 10-3)
, 8h after treatment
36186
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
1 |
1 |
|
3 |
1 |
2 |
|
1 |
1 |
3 |
2 |
3 |
2 |
1 |
|
|
3 |
|
| DCV_cysteine24_tce DCV cysteine (serum DCVC x 10-3)
, 24h after treatment
36187
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
|
|
|
1 |
|
|
1 |
1 |
|
|
1 |
3 |
3 |
|
3 |
|
|
|
| DCV_glutathione2_tce DCV glutathione (serum DCVG x 10-3)
, 2h after treatment
36195
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
1 |
|
3 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
2 |
2 |
3 |
2 |
|
|
| DCV_glutathione8_tce DCV glutathione (serum DCVG x 10-3)
, 8h after treatment
36196
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
3 |
2 |
2 |
3 |
3 |
3 |
3 |
3 |
1 |
3 |
3 |
2 |
2 |
1 |
2 |
|
3 |
|
| DCV_glutathione24_tce DCV glutathione (serum DCVG x 10-3)
, 24h after treatment
36197
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male |
2 |
|
|
1 |
3 |
1 |
3 |
1 |
1 |
1 |
1 |
|
|
1 |
3 |
|
|
|
